140 related articles for article (PubMed ID: 29880313)
1. Usefulness of The Piko-6 Portable Device for Early COPD Detection in Primary Care.
Hidalgo Sierra V; Hernández Mezquita MÁ; Palomo Cobos L; García Sánchez M; Castellanos RD; Jodra Sánchez S; Cordovilla Pérez R; Barrueco Ferrero M
Arch Bronconeumol (Engl Ed); 2018 Sep; 54(9):460-466. PubMed ID: 29880313
[TBL] [Abstract][Full Text] [Related]
2. Simplified COPD screening: validation of the PiKo-6® in primary care.
Frith P; Crockett A; Beilby J; Marshall D; Attewell R; Ratnanesan A; Gavagna G
Prim Care Respir J; 2011 Jun; 20(2):190-8, 2 p following 198. PubMed ID: 21597667
[TBL] [Abstract][Full Text] [Related]
3. Multicenter study of the COPD-6 screening device: feasible for early detection of chronic obstructive pulmonary disease in primary care?
Kjeldgaard P; Lykkegaard J; Spillemose H; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2017; 12():2323-2331. PubMed ID: 28831249
[TBL] [Abstract][Full Text] [Related]
4. Impact of body mass index on the predictive capacity of the COPD-6 device in the detection of airflow obstruction.
Figueira Gonçalves JM; Pérez Méndez LI; Guzmán Sáenz C; Díaz Pérez D; Viña Manrique P; Pedrero García AJ
Med Clin (Barc); 2017 Dec; 149(11):483-487. PubMed ID: 28669515
[TBL] [Abstract][Full Text] [Related]
5. FEV1/FEV6 in Primary Care Is a Reliable and Easy Method for the Diagnosis of COPD.
Wang S; Gong W; Tian Y; Zhou J
Respir Care; 2016 Mar; 61(3):349-53. PubMed ID: 26534998
[TBL] [Abstract][Full Text] [Related]
6. PIKO-6® vs. forced spirometry in asthmatic children.
Gochicoa-Rangel L; Larios-Castañeda PJ; Miguel-Reyes JL; Briseño DM; Flores-Campos R; Sáenz-López JA; Torre-Bouscoulet L
Pediatr Pulmonol; 2014 Dec; 49(12):1170-6. PubMed ID: 24500941
[TBL] [Abstract][Full Text] [Related]
7. FEV1/FEV6 is effective as a surrogate for FEV1/FVC in the diagnosis of chronic obstructive pulmonary disease.
Venkatachalam P; Dwivedi DP; Govindraj V
Indian J Tuberc; 2021 Apr; 68(2):230-235. PubMed ID: 33845957
[TBL] [Abstract][Full Text] [Related]
8. Validity of the Handheld Expiratory Flowmeter for COPD Screening in the Primary Care Setting of China.
Chen S; Li X; Wang Z; Zhou Y; Zhao D; Zhao Z; Liu S; Ran P
Int J Chron Obstruct Pulmon Dis; 2021; 16():2039-2047. PubMed ID: 34267511
[TBL] [Abstract][Full Text] [Related]
9. Comparison between FEV
Ng SC; Abu Samah F; Helmy K; Sia KK
Med J Malaysia; 2017 Oct; 72(5):286-290. PubMed ID: 29197884
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study.
van den Bemt L; Wouters BC; Grootens J; Denis J; Poels PJ; Schermer TR
NPJ Prim Care Respir Med; 2014 Aug; 24():14033. PubMed ID: 25119686
[TBL] [Abstract][Full Text] [Related]
11. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
[TBL] [Abstract][Full Text] [Related]
12. Determination of the efficacy of FEV6 as a surrogate for FVC in the diagnostic screening for chronic obstructive pulmonary disease through the comparison of FEV1/FVC and FEV1/FEV6 ratios.
Lundgren FL; Cabral MM; Clímaco DC; de Macedo LG; Coelho Mde A; Dias AL
J Bras Pneumol; 2007; 33(2):148-51. PubMed ID: 17724533
[TBL] [Abstract][Full Text] [Related]
13. Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry.
Kim JK; Lee CM; Park JY; Kim JH; Park SH; Jang SH; Jung KS; Yoo KH; Park YB; Rhee CK; Kim DK; Hwang YI
Medicine (Baltimore); 2016 Dec; 95(50):e5683. PubMed ID: 27977619
[TBL] [Abstract][Full Text] [Related]
14. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis.
Thorn J; Tilling B; Lisspers K; Jörgensen L; Stenling A; Stratelis G
Prim Care Respir J; 2012 Jun; 21(2):159-66. PubMed ID: 22270480
[TBL] [Abstract][Full Text] [Related]
15. Cut-off value of FEV1/FEV6 to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease.
Hwang YI; Kim Y; Rhee CK; Kim DK; Park YB; Yoo KH; Jung KS; Lee CY
Korean J Intern Med; 2021 May; 36(3):629-635. PubMed ID: 32575171
[TBL] [Abstract][Full Text] [Related]
16. Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings.
Represas-Represas C; Fernández-Villar A; Ruano-Raviña A; Priegue-Carrera A; Botana-Rial M;
PLoS One; 2016; 11(1):e0145571. PubMed ID: 26726887
[TBL] [Abstract][Full Text] [Related]
17. Comparison of New Spirometry Measures to Diagnose COPD.
Giraldo AMM; Cadavid LFG; Rosas DB; Quintero ET; Maldonado-Franco A; Murcia HCA; Suárez CEA; Cely LMM; Bastidas AR
Respir Care; 2023 Mar; 68(3):366-373. PubMed ID: 36414276
[TBL] [Abstract][Full Text] [Related]
18. Efficient screening for COPD using three steps: a cross-sectional study in Mexico City.
Franco-Marina F; Fernandez-Plata R; Torre-Bouscoulet L; García-Sancho C; Sanchez-Gallen E; Martinez D; Perez-Padilla R;
NPJ Prim Care Respir Med; 2014 May; 24():14002. PubMed ID: 24841708
[TBL] [Abstract][Full Text] [Related]
19. Which is the Best Screening Strategy for COPD among Smokers in Primary Care?
Llordés M; Zurdo E; Jaén Á; Vázquez I; Pastrana L; Miravitlles M
COPD; 2017 Feb; 14(1):43-51. PubMed ID: 27797591
[TBL] [Abstract][Full Text] [Related]
20. [Utility of normality low limit of spirometry in diagnosed COPD patients].
Naveiro-Rilo JC; García García S; Flores-Zurutuza L; Carazo Fernández L; Domínguez Fernández C; Palomo García JL
Rev Calid Asist; 2017; 32(5):262-268. PubMed ID: 28863965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
